ALFERON N INJECTION
Dead / Cancelled — Cancelled — Section 8 (as of 28 Jun 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74535420
- Registration number
- 1898544
- Mark type
- Word mark
- Filed
- 09 Jun 1994
- Published for opposition
- 21 Mar 1995
- Registered
- 13 Jun 1995
- Next maintenance due
- 13 Jun 2005
- Attorney of record
- EDWARD M. PRINCE
Goods and services
- Class 005 — Pharmaceuticals: parenterally administered interferon for use in treating viral diseases and immunological disorders
Owner
- HEMISPHERX BIOPHARMA, INC., PHILADELPHIA, PA, US
- Interferon Sciences, Inc., New Brunswick, NJ, US
- Interferon Sciences, Inc., New Brunswick, NJ, US
- Interferon Sciences, Inc., New Brunswick, NJ, US
Prior registrations
Prosecution history
- 28 Jun 2017 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 28 Jun 2007 — CASE FILE IN TICRS
- 26 Aug 2005 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 Aug 2005 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Aug 2005 — ASSIGNED TO PARALEGAL
- 10 Jun 2005 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 10 Jun 2005 — PAPER RECEIVED
- 10 Aug 2001 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jun 2001 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 13 Jun 1995 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 1995 — PUBLISHED FOR OPPOSITION
- 17 Feb 1995 — NOTICE OF PUBLICATION
- 13 Nov 1994 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Oct 1994 — EXAMINER'S AMENDMENT MAILED
- 21 Oct 1994 — ASSIGNED TO EXAMINER